SeekingAlpha · Sep 23, 2026
UCB SA (UCBJY) Presents at J.P. Morgan CEO Call Series Transcript
UCB SA (UCBJY) J.P. Morgan CEO Call Series September 23, 2026 11:15 AM EDTCompany ParticipantsJean-Christophe Tellier - CEO & Executive...
OTC · UCBJY
Healthcare · Biotechnology
$121.15
Down-$1.49 (-1.21%)
Updated Sep 28, 2026, 10:23 PM
SID Score
5.8/10
Composite research score
Smart Money
46/100
Neutral
Price performance · UCBJY
1M range · 0 trading sessions · Daily adjusted prices
UCBJY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning UCBJY.
UCBJY research
Company profile and research snapshot.
UCB SA UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 22, 2026 | TD COWEN | Buy | — |
| Sep 21, 2026 | BERENBERG | Buy | — |
| Sep 17, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Sep 4, 2026 | JEFFERIES | Hold | — |
| Sep 1, 2026 | DEGROOF PETERCAM | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Sep 23, 2026
UCB SA (UCBJY) J.P. Morgan CEO Call Series September 23, 2026 11:15 AM EDTCompany ParticipantsJean-Christophe Tellier - CEO & Executive...
SeekingAlpha · Sep 23, 2026
UCB SA (UCBJY) Bank of America Global Healthcare Conference 2026 September 23, 2026 6:45 AM EDTCompany ParticipantsSandrine Dufour - Executive VP &...
Yahoo · Sep 18, 2026
UCB (UCBJY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SeekingAlpha · Aug 1, 2026
UCB SA (UCBJY) Q2 2026 Earnings Call July 30, 2026 8:00 AM EDTCompany ParticipantsYvonne Naughton - Head of Investor RelationsJean-Christophe Tellier - CEO...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning UCBJY.